Executive Director, Strategy & Commercial Development, Neuroscience

About this role

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.

Position Summary The Executive Director, Neurodegeneration Strategy and Commercial Development will serve as the commercial leader accountable for maximizing the value of BMS's rapidly expanding neurodegeneration portfolio, spanning Alzheimer's disease, Parkinson's disease/Dementia with Lewy Bodies (DLB), and other neurodegenerative conditions. This position is responsible for defining and executing integrated strategy as well as managing a diverse pipeline of early- and mid-stage neurodegeneration assets, while also owning Market Development, building BMS’s presence in these new areas.

This role provides commercial leadership across the neurodegeneration pipeline from Discovery through Phase 3.  (S)he will partner closely with Development, Medical, Regulatory, CMC, Commercial, and Project Leadership to optimize development strategy, brand development, and market preparation for each asset, and will work closely with key markets, Business Insights & Analytics (BI&A), and Value, Access & Pricing (VAP) to ensure appropriate commercial input into product development decisions. (S)he will optimize the value of the neurodegeneration portfolio by identifying areas for growth, seeking opportunities within and beyond the organization to add value to long-term plans. This position will represent key products at the Global Program Team level and will be responsible for overall commercial direction for the neurodegeneration area.

In addition to pipeline and development strategy, this person will own Market– establishing strategic platforms to prepare the market for launch, shaping BMS's biomarker and diagnosis strategy, and building relationships with patient advocacy organizations, medical societies, and thought leaders. The Executive Director will lead the organization's efforts to shape BMS's presence in neurodegeneration, including defining commercialization strategies, understanding customer and market dynamics, and preparing for launches in these high-value emerging therapeutic spaces. The Executive Director will develop the long-range plan for neurodegeneration assets and partner to build out corporate presence in support of relevant products in development, guiding products through successful transition at key stage gates and representing key products to Executive Management.

The leader must be able to operate in a fast-paced organization, with high expectations and accountability on quality of deliverables and the ability to create an energizing, inclusive culture. Demonstrated ability to create strategy and to lead and influence across functions, including Clinical, Regulatory, MAx, Medical, BI&A, and cross-functional Commercial partners, is required. Leads Commercial Teams and represents commercial interests on Global Program Teams.

Domestic and International travel required (~20%).

Key Responsibilities • Leads worldwide brand planning and long-range forecasting across the neurodegeneration pipeline, including assets from Discovery through Phase 2b/3 in Alzheimer’s, Parkinson’s, and other neurodegenerative conditions.

• Owns Neurodegeneration Market Development, including biomarker and diagnosis strategy, patient identification pathways, and preparation of markets for launch

• Sets the strategic direction for neurodegeneration and also ensuring alignment of day-to-day execution with overall franchise strategy

• Ensures comprehensive assessment of competitive data and events, assesses emerging trends that could impact brands, and integrates implications into brand strategy and plans in rapidly evolving spaces that are new to BMS

• Translates new clinical and scientific evidence into brand strategy to maximize opportunities for appropriate patient usage

• Partners with opinion leaders, advocacy groups, external agencies, and other stakeholders to reinforce BMS's commitment to neurodegeneration, and to build BMS's presence in these areas

• Partners with WW Value, Access, and Pricing team to ensure optimized access and uptake at launch through optimized development strategies that meet future market needs

• Builds a deep understanding of local market dynamics, including customer and competitive insights, and identifies growth opportunities to drive global development and launch

• Leads and influences across functions and levels to guide optimized development for future commercial success

• Develops the strategic and long-range plan for neurodegeneration and guides products through successful transition at key stage gates, representing key products to Executive Management

• Demonstrates the ability to develop strategies and build relationships with stakeholders to establish BMS's presence in new neurodegeneration therapeutic areas

Qualifications & Experience • BA/BS required; life sciences degree or equivalent desirable. MBA / graduate degree highly preferred

• At least 12 years of progressive industry experience with a proven track record of success across products in various stages of development, from pipeline to launch to in-market

• US and Global experience preferred

• Functional experience within Alzheimer's Disease and/or movement disorders (Parkinson's/DLB) preferred

• Demonstrated scientific acumen; understanding of drug development processes and regulatory pathways, product design, and new product evaluation

• Understanding of the commercial aspects of drug development, including global/country market dynamics, operatio

Similar jobs

• Associate Director, Neuroscience Operations — Ipsen · Cambridge (US)
• Director, V&A Marketing & Strategy, Neuroscience — Ipsen · Cambridge (US) | New Jersey | North Carolina
• Senior Medical Director, Clinical Development, Neurology — Neurocrine · US CA San Diego
• Director, Neuroscience Portfolio Strategy — Johnson & Johnson · Titusville, New Jersey, United States | Cambridge, Massachusetts, United States | Raritan, New Jersey, United States
• Senior Medical Director, Clinical Development - Neurodegeneration — GSK · Waltham, Massachusetts, United States | Upper Providence, Pennsylvania, United States
• Vice President, Head of Medical Affairs, Neuroscience — Ipsen · Cambridge (US)
• Associate Director, Global Medical Neuroscience, Medical Communications — Bristol Myers Squibb · Princeton, NJ
• Executive Director, Therapeutic Strategy Lead, Oncology — Worldwide · Virtual United States North Carolina